This research group looked at five recently published studies to examine the effect of vitamin D supplementation on the relative risk of relapse in MS and found no association.
28 May 2013
New language editions now available! This edition of our magazine looks at many aspects of living with MS as a young person.
14 Feb 2013
More than 4,600 people with multiple sclerosis around the world took part in our survey about cognition and MS. We have now published the results.
05 Jun 2013
Read personal stories of MS from around the world
Frederica from Italy says "MS has had a big impact on my social life. I get angry and I feel like the problems other people have are minor compared to living with this disease."
MS in focus on young people with MS published
Results from our survey of young people with MS published
Thank you to the more than 4,600 respondents from over 100 countries who took part in our global survey for young people with MS.
Tobacco smoking and disability progression in MS: UK cohort study
This study demonstrated that regular smoking is associated with more severe disease as well as faster progression of disability. Stopping smoking either before or after the onset of MS is associated with slower progression of disability.
Confounding underlies the apparent month of birth effect in MS
Several groups have previously reported the apparent seasonal patterns for month of birth suggested to be specific to MS, that is to say increased in those born in spring and reduced in the winter. The analysis carried out by this study group indicates that the apparent seasonal patterns for month of birth are expected by chance alone and so are probably false positives.
Magnetic resonance frequency shifts during acute MS lesion formation
The researchers looked at a new imaging technique on the MRI scanner which detects an increase in frequency shifts of the MR signal. They found that the increase in MR frequency was seen one month before and one month after contrast enhanced lesions appeared on conventional MRI.
We are recruiting!
MSIF is looking for a Head of Communications and a Communications Manager. Come and join us!
Hopeful new MS treatment
A small, exploratory/feasibility trial in just 10 patients has shown that a new therapy for MS that teaches the immune system to recognise and ignore its own nerve tissue, appears to be safe and well tolerated in humans.
Results of our cognition and MS survey
Find your nearest MS organisation
© Multiple Sclerosis International Federation
http://www.msif.org/default.aspx?page_id=15
Tuesday, 18 June 2013 23:10